SCHEMBL25719241

SCHEMBL25719241

COP(=O)(O)OP(=O)(OC)OP(=O)(OC)OC[C@H]1O[C@@H](C)[C@H](OC(C)=O)[C@@H]1COC(C)=O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 7/20 0.34
▸ CYP2D6 P10635 1/20 0.33
▸ THRB P10828 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ NR3C1 P04150 1/20 0.33
▸ FYN P06241 1/20 0.33
▸ ADRA2A P08913 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33
▸ ADRA2B P18089 1/20 0.33
▸ DRD4 P21917 1/20 0.33
▸ DRD3 P35462 1/20 0.33
▸ CA12 O43570 6/20 0.32
▸ CA1 P00915 6/20 0.32
▸ CA9 Q16790 6/20 0.32
▸ PKM P14618 1/20 0.30
▸ PTPN1 P18031 1/20 0.30
▸ P2RY2 P41231 1/20 0.30
▸ P2RY4 P51582 1/20 0.30
▸ P2RY14 Q15391 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25712624 0.79 P2RY2 (0.37) CA2CYP2D6THRBHSD17B10TSHR
SCHEMBL12111813 0.78 THRB (0.49) CA2CYP2D6THRBHSD17B10TSHR
SCHEMBL25719257 0.77 FBP1 (0.34) P2RY2P2RY4P2RY14
SCHEMBL11923052 0.76 FBP1 (0.44) P2RY2P2RY4P2RY14
SCHEMBL25719140 0.76 P2RY14 (0.33) P2RY2P2RY4P2RY14
SCHEMBL6973818 0.70 CYP2D6 (0.42) CA2CYP2D6THRBHSD17B10TSHR
SCHEMBL22592286 0.68 THRB (0.57) CA2CYP2D6THRBHSD17B10TSHR
SCHEMBL16358235 0.68 THRB (0.57) CA2CYP2D6THRBHSD17B10TSHR
SCHEMBL22516447 0.68 THRB (0.57) CA2CYP2D6THRBHSD17B10TSHR
SCHEMBL20711502 0.68 THRB (0.57) CA2CYP2D6THRBHSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3131914-B1 3'-SUBSTITUTED METHYL OR ALKYNYL NUCLEOSIDES FOR THE TREATMENT OF HCV IDENIX PHARMACEUTICALS LLC (US) 2023-05-10 — — EP disclosed
Send feedback